tiprankstipranks
Vistagen granted patent for PH80 nasal spray from USPTO
The Fly

Vistagen granted patent for PH80 nasal spray from USPTO

Vistagen announced that the U.S. Patent and Trademark Office, or USPTO, has granted a U.S. patent for Vistagen’s PH80 nasal spray for treatment of migraine. The newly issued patent will be in effect until at least 2040.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles